This inventor holds 1 USPTO granted patent and 7 published patent applications, plus 2 CIPO patents. Top assignee: University of Oklahoma. Active years: 2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2015
Title: Rico Buchli: Innovator in Epitope Testing
Introduction
Rico Buchli is an accomplished inventor based in Edmond, OK (US). He has made significant contributions to the field of epitope testing, particularly through his innovative methodologies. His work focuses on the binding of peptides to specific soluble HLA molecules, which has important implications in immunology and personalized medicine.
Latest Patents
Rico Buchli holds a patent for "Epitope testing using soluble HLA." This invention relates to a methodology for assaying the binding of a peptide to an individual, specific, soluble HLA molecule using fluorescence polarization. The peptides utilized in this method may be identified through indirect methods involving T lymphocytes or by a direct method of epitope discovery.
Career Highlights
Rico Buchli is affiliated with the University of Oklahoma, where he continues to advance research in his field. His work has garnered attention for its potential applications in understanding immune responses and developing targeted therapies.
Collaborations
Rico has collaborated with notable colleagues, including William H. Hildebrand and Steven Cate. These partnerships have contributed to the advancement of research in epitope testing and related areas.
Conclusion
Rico Buchli's innovative work in epitope testing exemplifies the impact of research on immunology. His contributions are paving the way for advancements in personalized medicine and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile